Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Prognostic Gene Signatures for Survival of Patients With Phaeochromocytoma, Paraganglioma, and Other Tumor Types. | Cancer Diagn Progn | 2025 | 41179328 | PubTator, text mining | PubMed |
| Comprehensive Analysis Identifies Tumor Mutation Burden-associated Genes ASPM and KIF11 as Novel Biomarkers for Adrenocortical Carcinoma. | Curr Cancer Drug Targets | 2025 | 41178767 | PubTator, text mining | PubMed |
| BUB1B Promotes Ovarian Cancer Cell Proliferation and Metastasis by Activating the Wnt/β-Catenin Pathway. | Cancer Med | 2025 | 41163302 | PubTator, text mining | PubMed |
| Inhibitory Effects of Hesperetin and EGCG in the Lung Cancer Progression involves impairment in TOP2A gene expression regulation. | Appl Biochem Biotechnol | 2025 | 41074927 | PubTator, text mining | PubMed |
| CKS2 is overexpressed in high-grade and recurrent meningiomas and functions as an oncogene via the CKS2/miR-26a/miR-101 axis. | Comput Biol Med | 2025 | 41061391 | PubTator, text mining | PubMed |
| Chromosomal Instability as a Driver of Therapeutic Resistance and Phenotypic Plasticity in Non-Small Cell Lung Cancer. | J Cell Mol Med | 2025 | 41017032 | PubTator, text mining | PubMed |
Fucoxanthin protects placenta-derived human mesenchymal stem cells against oxidative stress-induced apoptosis by modulating genes involved in DNA damage repair, ER stress response, p53-induced apoptosis. | Stem Cell Res Ther | 2025 | 40999517 | PubTator, text mining | PubMed |
| The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous corona. | Sci Adv | 2025 | 40938979 | PubTator, text mining | PubMed |
| BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway. | Oncol Rep | 2025 | 40910254 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals SGO1 as a potential cancer prognostic and immunological biomarker. | J Cancer | 2025 | 40861810 | PubTator, text mining | PubMed |
| BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities. | Eur J Med Res | 2025 | 40859340 | PubTator, text mining | PubMed |
| CENcyclopedia: dynamic landscape of kinetochore architecture throughout the cell cycle. | Nat Commun | 2025 | 40825761 | PubTator, text mining | PubMed |
| 3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. | Hemasphere | 2025 | 40809351 | PubTator, text mining | PubMed |
| A noncanonical cytoplasmic role for BUB1 in restraining DNA damage-induced dsRNA accumulation and sensing within stress granules. | Sci Immunol | 2025 | 40779648 | PubTator, text mining | PubMed |
| Identification of IQGAP3 prognostic potential and involvement in immune cell infiltration in LUAD. | Eur J Med Res | 2025 | 40760442 | PubTator, text mining | PubMed |
| Methionine Deprivation-induced Cancer Cell Death and Methylation Changes in Key Genes and Gene Promoters of Prostate Cancer Cell Lines. | Anticancer Res | 2025 | 40750410 | PubTator, text mining | PubMed |
| Research on biliary atresia and epigenetic factors from the perspective of transcriptomics: identification of key genes and experimental validation. | Front Pediatr | 2025 | 40746357 | PubTator, text mining | PubMed |
| PIPKIγ promotes non-homologous end joining through LIG4 to enhance radiotherapy resistance in triple-negative breast cancer. | Cell Death Dis | 2025 | 40744919 | PubTator, text mining | PubMed |
| BUB1 an Overexpressed Kinase in Sarcoma: Finding New Target Therapy for Osteosarcoma, Liposarcoma, Synovial Sarcoma, and Leiomyosarcoma. | Biomolecules | 2025 | 40723917 | PubTator, text mining | PubMed |
| Author Correction: DTL promotes the growth and migration of melanoma cells through the ERK/E2F1/BUB1 axis. | Sci Rep | 2025 | 40702100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=5